National trends in drug overdose mortality among Asian American, Native Hawaiian, and Pacific Islander populations

IF 3.3 3区医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Annals of Epidemiology Pub Date : 2025-01-01 DOI:10.1016/j.annepidem.2024.12.005

David T. Zhu , Andrew Park

{"title":"National trends in drug overdose mortality among Asian American, Native Hawaiian, and Pacific Islander populations","authors":"David T. Zhu , Andrew Park","doi":"10.1016/j.annepidem.2024.12.005","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>To analyze drug overdose mortality trends among Asian American and Native Hawaiian/Pacific Islander (AANHPI) populations.</div></div><div><h3>Methods</h3><div>We obtained data on drug overdose deaths and population totals from CDC WONDER and the American Community Survey (2018–2022). Crude mortality rates per 100,000 were calculated overall and by sex, U.S. Census Division, and drug type. Disaggregated analyses included six Asian American subgroups (Asian Indian, Chinese, Filipino, Japanese, Korean, and Vietnamese) and three NHPI subgroups (Native Hawaiian, Guamanian, and Samoan).</div></div><div><h3>Results</h3><div>In 2022, Asian Americans had 1226 drug overdose deaths and NHPI individuals had 154. The mortality rate for NHPI individuals (17.52 [95 % CI: 14.76–20.29] per 100,000) tripled that of Asian Americans (5.85 [95 % CI: 5.52–6.18] per 100,000). Fentanyl was the leading drug-related death among Asian Americans (3.17 [95 % CI: 2.93–3.41] per 100,000), while methamphetamine led for NHPI individuals (11.38 [95 % CI: 9.15–13.61] per 100,000). Disaggregated mortality rates were highest for Korean Americans (9.06 [95 % CI: 8.88–9.24] per 100,000) and Guamanians (43.16 [95 % CI: 39.05–48.24] per 100,000) among the Asian American and NHPI subgroups, respectively.</div></div><div><h3>Conclusions</h3><div>AANHPI populations experience distinct overdose mortality patterns, with NHPI individuals and specific ethnic subgroups disproportionately affected, warranting targeted public health interventions.</div></div>","PeriodicalId":50767,"journal":{"name":"Annals of Epidemiology","volume":"101 ","pages":"Pages 36-41"},"PeriodicalIF":3.3000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Epidemiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1047279724002771","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose

To analyze drug overdose mortality trends among Asian American and Native Hawaiian/Pacific Islander (AANHPI) populations.

Methods

We obtained data on drug overdose deaths and population totals from CDC WONDER and the American Community Survey (2018–2022). Crude mortality rates per 100,000 were calculated overall and by sex, U.S. Census Division, and drug type. Disaggregated analyses included six Asian American subgroups (Asian Indian, Chinese, Filipino, Japanese, Korean, and Vietnamese) and three NHPI subgroups (Native Hawaiian, Guamanian, and Samoan).

Results

In 2022, Asian Americans had 1226 drug overdose deaths and NHPI individuals had 154. The mortality rate for NHPI individuals (17.52 [95 % CI: 14.76–20.29] per 100,000) tripled that of Asian Americans (5.85 [95 % CI: 5.52–6.18] per 100,000). Fentanyl was the leading drug-related death among Asian Americans (3.17 [95 % CI: 2.93–3.41] per 100,000), while methamphetamine led for NHPI individuals (11.38 [95 % CI: 9.15–13.61] per 100,000). Disaggregated mortality rates were highest for Korean Americans (9.06 [95 % CI: 8.88–9.24] per 100,000) and Guamanians (43.16 [95 % CI: 39.05–48.24] per 100,000) among the Asian American and NHPI subgroups, respectively.

Conclusions

AANHPI populations experience distinct overdose mortality patterns, with NHPI individuals and specific ethnic subgroups disproportionately affected, warranting targeted public health interventions.

查看原文本刊更多论文

亚裔美国人、夏威夷原住民和太平洋岛民中药物过量死亡率的全国趋势。

目的：分析亚裔美国人和夏威夷原住民/太平洋岛民（AANHPI）人群的药物过量死亡率趋势。方法：我们从CDC WONDER和美国社区调查（2018-2022）中获得药物过量死亡和人口总数的数据。每10万人的粗死亡率按总体、性别、美国人口普查局和药物类型计算。分类分析包括6个亚裔美国人亚组（亚洲印度人、中国人、菲律宾人、日本人、韩国人和越南人）和3个NHPI亚组（夏威夷人、关岛人和萨摩亚人）。结果：2022年，亚裔美国人有1226例药物过量死亡，非裔美国人有154例。NHPI个体的死亡率（17.52 [95% CI: 14.76-20.29] / 10万）是亚裔美国人的三倍（5.85 [95% CI: 5.52-6.18] / 10万）。芬太尼是亚裔美国人中最主要的药物相关死亡（每10万人中有3.17人[95% CI: 2.93-3.41]），而甲基苯丙胺是NHPI人群中最主要的药物相关死亡（每10万人中有11.38人[95% CI: 9.15-13.61]）。在亚裔美国人和NHPI亚组中，韩裔美国人和关岛人的分类死亡率分别最高（9.06 [95% CI: 8.88-9.24] / 10万）和43.16 [95% CI: 39.05-48.24] / 10万)。结论：AANHPI人群经历了不同的过量死亡模式，NHPI个人和某些亚群不成比例地受到影响，需要有针对性的公共卫生干预。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Annals of Epidemiology 医学-公共卫生、环境卫生与职业卫生

CiteScore

7.40

自引率

1.80%

发文量

207

审稿时长

59 days

期刊介绍： The journal emphasizes the application of epidemiologic methods to issues that affect the distribution and determinants of human illness in diverse contexts. Its primary focus is on chronic and acute conditions of diverse etiologies and of major importance to clinical medicine, public health, and health care delivery.